PharmaSeq, Inc., is the inventor and sole manufacturer of the p-Chip, the world’s first and only ultra-small microtransponder that emits a unique serial number when illuminated with laser light. It functions as a crypto anchor, associating a unique, unchangeable identifier with a physical object, to create a digital twin.
With a uniquely traceable, light-activated micro-transponder (a silicon microchip), ultra-secure p-Chips track, connect and authenticate goods across the supply chain.
In 1999, PharmaSeq, Inc. began the research and development efforts that would lead to the p-Chip. Founder Dr. Wlodek Mandecki invented the light-activated micro-transponder, which was registered under the trademark p-Chip® in 2012.
The Company began commercial operations in late 2011, initiating sales for tagging and tracking small laboratory animals.
The p-Chip was originally developed with an Advanced Technology Program grant from the U.S. National Institute of Standards Technology (NIST). PharmaSeq later expanded its expertise to include scientific instrument design, electrical and mechanical engineering, optics, material science, software and molecular biology.
In 2021, PharmaSeq, Inc. was officially acquired by p-Chip Corp.
Contact us for more information.